Igm Biosciences, Inc.
IGMS
Revenue
0.00
0.000.00%
-Assets
336.50M
▼-39.63M▼-10.54%
3 Months ChangeLiabilities
214.14M
▼-736.00k▼-0.3425%
3 Months ChangeFree Cash Flow
-44.90M
▲10.03M▲18.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0001193125-24-232252
2024-08-14
Form 8-K
ID: 0000950170-24-096641
2024-08-14
Form 10-Q
ID: 0000950170-24-096639
2024-07-05
Form 8-K
ID: 0000950170-24-081867
2024-06-14
Form 8-K
ID: 0000950170-24-073354
2024-05-08
Form 8-K
ID: 0000950170-24-055654
2024-05-08
Form 10-Q
ID: 0000950170-24-055615
2024-04-17
Form 8-K
ID: 0000950170-24-044931
2024-03-07
Form 8-K
ID: 0000950170-24-027952
2024-01-08
Form 8-K
ID: 0000950170-24-002737